Skip to main content
SpringerLink
Log in

Non enzymatic glycosylation of IgG and their urinary excretion in patients with diabetic nephropathy

  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Diabetic nephropathy is a major cause of end stage renal disease. Increased excretion of albumin has widely been recognized as an early manifestation of diabetic nephropathy particularly in subjects with diabetes mellitus. However, certain other proteins besides albumin may be excreted in high amount during early phase of diabetic nephropathy. The serum and urinary IgG, Glycosylated hemoglobin, fructosamine and glycosylated IgG were evaluated in the present study. Thirty-two patients of Type 2 Diabetes without any complications, thirty-one patients of Type 2 Diabetes with nephropathy, twenty-six patients of non-diabetic nephropathy and forty normal healthy individuals were enrolled in this study. Subjects were grouped based on their serum creatinine level. Serum IgG, glycosylation of IgG and urinary IgG excretion were increased significantly in diabetic patients compared to healthy controls, which were further increased significantly in chronic renal failure patients with respect to the clinical stage of nephropathy. A positive correlation was observed between glycosylation of IgG and IgG excretion (R2=0.5995, 0.7114 respectively) in diabetic patients without any complications and diabetic nephropathy patients only, suggesting a significant role of IgG glycosylation in the vascular clearances of IgG during diabetic nephropathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fitz Simmons SC, Agodoa L, Striker L, Conti F. Kidney disease of diabetes mellitus: NIDDK initiatives for the comprehensive study of its natural history, pathogenesis and prevention. Am J Kidney Dis 1989; 13: 7–10.

    CAS  Google Scholar 

  2. Wang PH, Lau J, Chalmer TC. Meta-analysis of effects of intensive blood-glucose control on late complications of Type I diabetes. Lancet 1993; 341(8856): 1306–1309.

    Article  PubMed  CAS  Google Scholar 

  3. Fukami K, Yamagishi S, Ueda S, Okuda S. Role of AGEs in diabetic nephropathy. Curr Pharm Des 2008; 14(10): 946–952.

    Article  PubMed  CAS  Google Scholar 

  4. Deckert T, Feldt Rasmussen B, Djurup R, Fossatie P, Dautrevaux M. Glomerular size and charge selectivity in insulin dependent diabetes mellitus. Kidney International 1988; 33: 100–106.

    Article  PubMed  CAS  Google Scholar 

  5. Mogensen CE. Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney International 1987; 31: 673–689.

    Article  PubMed  CAS  Google Scholar 

  6. Reddi AS, Camerini-Davalos RA. Diabetic nephropathy. Arch Intern Med 1990; 150: 31–43.

    Article  PubMed  CAS  Google Scholar 

  7. Narita T, Fujita H, Koshimura J, Meguro H, Kiatazto H, Shimotomai T, et al. Glycemic control reverses increases in urinary excretion of immunoglobulin G and ceruloplasmin in type 2 Diabetic patients with normoalbuminuria. Horm Metab Res 2001; 33: 370–378.

    Article  PubMed  CAS  Google Scholar 

  8. O’Donnel MJ, Martin P, Florkowski CM, Toop MJ, Chapman C, Holder R. Urinary excretion of transferrin in type 1 diabetes mellitus. Diabet Med 1991; 8: 657–661.

    Article  Google Scholar 

  9. Yamazaki M, Ito S, Usami A, Tani N, Hanyu O, Nakagawa O, Nakamura H, Shibata A. Urinary excretion rate of ceruloplasmin in non-insulin dependent diabetic patients with different stage of nephropathy. Eur J Endocrinol 1995; 132: 681–687.

    Article  PubMed  CAS  Google Scholar 

  10. Ito S, Tsuda A, Momopsu T, Igarashi K, Kasashara S, Satoh K, Shibata A. Urinary orosomucoid excretion rate in patients with non-insulin dependent diabetes mellitus. Acta Endocrino(Copenh) 1989; 120: 584–590.

    CAS  Google Scholar 

  11. Arunan K. Purification of immunoglobulins of different classes. In: A handbook of practical and clinical immunology Ed. Talwar GP, Gupta SK. Vol. 2, NewDelhi: CBS Publisher 1992; 127–130.

    Google Scholar 

  12. Winzler RJ. Departmentation of serum glycoprotein. In: Methods in biochemical analysis. Vol 2, Inter Sicence Publishers, New York, Glick 1955; 27.

    Google Scholar 

  13. Johnson RN, Metcafs PA, and Baker JR. Fructosamine: A new approach to the estimation of serum glycosylation. An index of diabetic control. Clin Chem Acta 1983; 127: 87–92.

    Article  CAS  Google Scholar 

  14. Fluckiger R, Winterhalter KH. In vitro synthesis of HbA1C. FEBS letter 1976; 71: 356–358.

    Article  CAS  Google Scholar 

  15. Goldstein DE, Little RR, Wiedmeyer HM. Glycated hemoglobin methodologies and clinical application. Clin Chem 1986; 32: 64–70.

    Google Scholar 

  16. DCCT research group 1993, Diabetes control and complications trial (DCCT). The effect of intensive treatment of diabetes on the development and progression of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Eng J Med 1993; 329: 977–986.

    Article  Google Scholar 

  17. David EB, Peter IL, John S. Specific affinity-chromatographic measurement of glycated hemoglobin in uremic patients. Clin Chem 1984; 30: 569–571.

    Google Scholar 

  18. Delattre J, Rottembourg J, Thuillier Juteau Y. Value of plasma fructosamine in non-diabetic and diabetic chronic renal failure. Presse Med 1989; 4:8 (36): 1781–1784.

    Google Scholar 

  19. Sian T, Reema R, Zein EL. Automated fructosamine assay with improved accuracy used to quantify non-enzymatic glycation of serum protein in diabetes mellitus and chronic renal failure. Clin Chem 1990; 36: 1825–1830.

    Google Scholar 

  20. Koskinen P, Erkkola R, Viikari J, Mattila K. Blood glycated hemoglobin, serum fructosamine, serum glycated albumin and serum glycated total protein as measures of glycemic in diabetes mellitus. Scand J Clin lab Invest 1992; 52(8): 863–869.

    Article  PubMed  CAS  Google Scholar 

  21. Selvaraj N, Bobby Z, Das A, Ramesh R, Chandra K. An evaluation of level of oxidative stress and protein glycation in nondiabetic undialyzed chronic renal failure patients. Clin Chem Acta 2002; 324: 45.

    Article  CAS  Google Scholar 

  22. Cassey JI. Host defense and infections in diabetes mellitus. In — Diabetes Mellitus: Theory and Practice. 3rd Eds. 1983; 667–678.

  23. Ardawi MS, Nasat HA, Bahnassy AA. Serum immunoglobulin concentrations in diabetic patients. Diabet Med 1994; 11(4): 384–387.

    PubMed  CAS  Google Scholar 

  24. Pietruska Z, Kinalska I, Jablonska E, Czaczkowska T. Serum immunoglobulins and various components of complement in patients with insulin-dependent diabetes mellitus. Przegl Lek 1989; 46(3): 338–341.

    PubMed  CAS  Google Scholar 

  25. Haroun M, M El-Sayed M. Measurement of IgG levels can serve as a biomarker in newly diagnosed diabetic children. J Clin Biochem Nutr 2007; 40(1):56–61.

    Article  PubMed  CAS  Google Scholar 

  26. Danze PM, Tarjoram A, Rousseaux J, Fossatie P, Dautrevau XM. Evidence for an increased glycation of IgG in diabetic patients. Clin Chem Acta 1987; 166: 143–153.

    Article  CAS  Google Scholar 

  27. Dolhofer R, Siess EA, Wieland OH. Non-enzymatic glycation of immunoglobulins leads to an impairment of immunoreactivity. Biol Chem Hoppen Seyler 1985; 366(4): 361–366.

    CAS  Google Scholar 

  28. Hammes HP, Kiefel V, Laube H, Federlin K. Impaired agglutination of IgM resulting from non enzymatic glycation in diabetes mellitus. Diabetes Res Clin Prac 1990; 9(1): 37–42.

    Article  CAS  Google Scholar 

  29. Kennedy DM, Skillen AW, Self CH. Glycation of monoclonal antibodies impairs their ability to antigen. Clin Exp Immunol 1994; 98: 245–251.

    PubMed  CAS  Google Scholar 

  30. Thomas MC, Forbes JM, Cooper ME. Advanced glycation end products and diabetic nephropathy. Am J Ther 2005; 12(6):562–572.

    Article  PubMed  Google Scholar 

  31. Gasser A, Forbes JM. Advanced glycation: implications in tissue damage and disease. Protein Pept Lett 2008; 15(4): 385–391.

    Article  PubMed  CAS  Google Scholar 

  32. Goh SY, Cooper ME. Clinical review: The role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab 2008; 93(4):1143–1152.

    Article  PubMed  CAS  Google Scholar 

  33. Goldin A, Beckman JA, Schmidt AM, Creager MA. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 2006; 114(6):597–605.

    Article  PubMed  CAS  Google Scholar 

  34. Kennedy D, Skillen AW, Self CH. Glycation increases the vascular clearance rate of IgG in mice. Clin Exp Immunol 1993; 94(3): 447–451.

    Article  PubMed  CAS  Google Scholar 

  35. Yashima T, Hirayama T, Shiiki H, Kanauchi M, Dohi K. Diagnostic significance of urinary immunoglobulin G in diabetic nephropathy. Nippon Jinzo Gakkaishi 1999; 41(8): 787–796.

    CAS  Google Scholar 

  36. Ohmachi T. Clinical significance of urinary albumin and IgG in diabetic nephropathy. Kinki Daigaku Igaku Zasshi 1991; 16(2): 353–64.

    CAS  Google Scholar 

  37. Torffvit O, Rippe B. Size and charge selectivity of the glomerular filter in patients with insulin dependent diabetes mellitus: Urinary immunoglobulins and glycosaminoglycans. Nephron 1999; 83(4): 301–307.

    Article  PubMed  CAS  Google Scholar 

  38. Gambardella S, Morano S, Cancelli A, Pietravalle P, Frontonis Baccis Di, Mariao U, Andreani D. Urinary IgG4: an additional parameter in characterizing patients with incipient diabetic nephropathy. Diabetes Res 1989; 10(4): 153–157.

    PubMed  CAS  Google Scholar 

  39. Tencer J, Torffvit O, Thysell H, Rippe B, Grubb A. Urine IgG2/IgG4-ratio indicates the significance of the charge selective properties of the glomerular capillary wall for the macromolecular transport in glomerular disease. Nephrol Dial Trasplant 1999; 14(6): 1425–1429.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ashok and Rita Patel Institute of Integrated Study & research in biotechnology and allied sciences (ARIBAS), New Vidyanagar, 388 121, India

    Kinnari Mistry

  2. BRD School of Biosciences, Sardar Patel University, Vallabh Vidyanagar, 388 120, Gujarat, India

    Kiran Kalia

Authors
  1. Kinnari Mistry
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kiran Kalia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kiran Kalia.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mistry, K., Kalia, K. Non enzymatic glycosylation of IgG and their urinary excretion in patients with diabetic nephropathy. Indian J Clin Biochem 24, 159–165 (2009). https://doi.org/10.1007/s12291-009-0029-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-009-0029-7

Key Words

Search

Navigation